1. Main page
  2. Biotechnology
  3. Compugen

Compugen

2 Decision Makers · 4 Verified Contacts

compugen.com
📍 Tel Aviv, Tel Aviv, IsraelBiotechnology🗓 Est. 1993👥 51–100 employees

About Compugen

Compugen is a drug and diagnostic discovery company, addressing important unmet therapeutic and diagnostic needs.

Leadership & Decision Makers

Contact details of 2 Compugen decision makers

Anat Cohen-Dayag

President & CEO

  • Work email

    a****d@cgen.com

Simchon Faigler

Co-Founder

Team & Specialists

Contact details of 2 Compugen team members

Michelle Mahler

Vice President Clinical Development,Chief Medical Officer

Ari Krashin

CFO & COO,CFO

General Emails

General company emails, e.g. customer support lines

    jobs@cgen.com

    Career Opportunities

    u003eir@cgen.com

    Investor Relations

    ir@cgen.com

    Investor Relations

    amartin@cgen.com

    Unclassified inbox

    nirr@cgen.com

    Unclassified inbox

    marketing@compugen.com

    Marketing Team

    emerge@compugen.com

    Unclassified inbox

Verify Compugen Emails

Similar Companies like Compugen

Thermo Fisher Scientific

thermofisher.com
Biotechnology · Waltham, MA · Est. 1956 · Above 10001 employees

HQ: Waltham, MA

ZOLL Medical Corporation

zoll.com
Biotechnology · Chelmsford, Massachusetts, United States · Est. 1980 · 1001–5000 employees

HQ: Chelmsford, Massachusetts, United States

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 09/09/2025

compugen.com

+972 3-765-8585

Tel Aviv, Tel Aviv, Israel

Specialization: Project Management,
Legal Name: Compugen Ltd.
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Founded Date: Feb 1993
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CGEN
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +972 3-765-8585
Last Investment Activity: Feb 15, 2024
Investments Activity: Feb 15, 2024 May 10, 2022 Nov 11, 2021

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.